部分半月板缺损胶原半月板植入物存活率的影响因素:156例连续病例平均10年随访分析
该病例对照研究纳入156例因部分半月板缺损接受胶原半月板植入物(CMI)植入或联合手术的患者,平均随访10.9±4.3年,总存活率87.8%。Outerbridge 3-4级(HR 3.8)、外侧半月板植入物(HR 3.2)、半月板切除至植入时间>10年(HR 2.8)是失败的危险因素。
要点
- CMI平均10.9年随访存活率87.8%,内侧植入物90.4%高于外侧77.4%。
- Outerbridge 3-4级是临床和手术失败的独立危险因素。
- 外侧半月板植入物及半月板切除至植入时间>10年与失败风险升高相关。
核心结论
- CMI治疗部分半月板缺损长期结果良好,平均10.9年随访时87.8%的植入物仍在原位。
- Outerbridge 3-4级、外侧半月板植入物及半月板切除至CMI植入时间较长被确定为临床和手术失败的危险因素。
研究设计与样本
- 病例对照研究,证据等级3级,单机构连续纳入186例接受CMI支架植入或联合手术且随访至少5年的患者。
- 通过病历回顾获取患者特征和手术细节,最终分析纳入156例(84%),平均随访10.9±4.3年。
- 临床失败定义为Lysholm评分<65分,手术失败定义为部分或全部支架取出。
主要发现
- 156例患者手术时平均年龄42.0±11.1岁,总存活率87.8%。
- 亚组分析显示Outerbridge 3-4级(HR 3.8,P=0.004)和外侧半月板植入物(HR 3.2,P=0.048)是失败的危险因素。
- 内侧植入物存活率90.4%,外侧植入物存活率77.4%。
- Outerbridge 3-4级(HR 2.8,P<0.001)和半月板切除至支架植入时间>10年(HR 2.8,P=0.020)可预测手术或临床失败。
关键数值与推荐
- 临床失败判定标准为Lysholm评分<65分。
- 手术失败判定标准为部分或全部支架取出。
- Outerbridge 3-4级预测任何失败的HR为3.8(P=0.004),预测手术或临床失败的HR为2.8(P<0.001)。
- 外侧半月板植入物预测失败的HR为3.2(P=0.048)。
- 半月板切除至支架植入时间>10年预测手术或临床失败的HR为2.8(P=0.020)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Collagen meniscal implant (CMI) is a biologic scaffold that can be used to replace meniscus host tissue after partial meniscectomy. The short-term results of this procedure have already been described; however, little is known about risk factors for failure. PURPOSE: To determine the factors that predict failure of meniscal scaffold implantation in a large series of patients treated at a single institution and to better define the indications for surgery. STUDY DESIGN: Case-control study; Level of evidence, 3. METHODS: The analysis included 186 consecutive patients with a minimum 5-year follow-up who underwent CMI scaffold implantation or combined procedures. Patients' characteristics and details of the surgery were obtained via chart review. Patients with a Lysholm score <65 were considered to have experienced clinical failure. Surgical failure was defined as partial or total scaffold removal. RESULTS: The final analysis included 156 patients (84%) at a mean follow-up of 10.9 ± 4.3 years. The patients' mean age at surgery was 42.0 ± 11.1 years, and the survival rate was 87.8%. Subgroup analysis identified Outerbridge grade 3-4 (Hazard ratio [HR], 3.8; P = .004) and a lateral meniscal implant (HR, 3.2; P = .048) as risk factors for failure. The survival rate was 90.4% for medial implants and 77.4% for lateral implants. An Outerbridge grade 3-4 (HR, 2.8; P < .001) and time from meniscectomy to scaffold >10 years (HR, 2.8; P = .020) were predictive of surgical or clinical failure. CONCLUSION: CMI for partial meniscal deficiency provided good long-term results, with 87.8% of the implants still in situ at a mean 10.9 years of follow-up. Outerbridge grade 3-4, lateral meniscal implants, and longer time from the meniscectomy to implantation of the CMI were identified as risk factors for clinical and surgical failure.
引用
- Lucidi GA, Grassi A, Agostinone P, et al. Risk Factors Affecting the Survival Rate of Collagen Meniscal Implant for Partial Meniscal Deficiency: An Analysis of 156 Consecutive Cases at a Mean 10 Years of Follow-up. Am J Sports Med. 2022. PMID: 35924871. doi:10.1177/03635465221112635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。